Role of tyrosine-57 and -65 in membrane-damaging and sphingomyelinase activities of Clostridium perfringens alpha-toxin  by Nagahama, Masahiro et al.
.elsevier.com/locate/bbaBiochimica et Biophysica ActaRole of tyrosine-57 and -65 in membrane-damaging and sphingomyelinase
activities of Clostridium perfringens alpha-toxin
Masahiro Nagahama, Akiko Otsuka, Jun Sakurai *
Department of Microbiology, Faculty of Pharmaceutical Sciences, Tokushima Bunri University, Yamashiro-cho, Tokushima 770-8514, Japan
Received 22 June 2005; received in revised form 30 September 2005; accepted 3 October 2005
Available online 25 October 2005Abstract
Clostridium perfringens alpha-toxin (370 residues) is a major virulence factor in the pathogenesis of gas gangrene. The toxin is composed of
an N-terminal domain (1–250 residues) where lies the catalytic site and a C-terminal domain (251–370 residues), the Ca2+-binding domain,
responsible for binding to membranes. The role of Tyr-57 and Tyr-65 close to the catalytic pocket (site) in the N-domain was investigated.
Replacement of Tyr-57 and -65 with alanine, leucine, or phenylalanine did not affect the sphingomyelinase activity of the toxin for sodium
deoxycholate-solubilized shingomyelin. However, the substitution of Tyr-57 and -65 with alanine or leucine resulted in a radical reduction in the
hemolysis of sheep erythrocytes, the release of carboxyfluorescein from shingomyelin-cholesterol (1:1) liposomes, and a significant decrease in
binding to the liposomes. The binding of variant toxins, Y57C/C169L and Y65C/C169L, labeled with the environmentally sensitive fluorophore,
acrylodan, to the liposomes suggested insertion of the variants in a hydrophobic environment in the bilayer. These observations suggested that Tyr-
57 and -65 play a role in the penetration of the toxin into the bilayer of membranes and access of the catalytic site to sphingomyelin in membranes,
but do not participate in the enzymatic activity.
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Clostridium perfringens alpha-toxin hydrolyzes phosphati-
dylcholine and sphingomyelin and is involved in various
biological activities, including hemolysis, necrosis, the
contraction of blood vessels and the ileum, and the
aggregation of platelets [1–3]. We have reported that the
alpha-toxin-induced contraction of isolated rat aorta and
ileum [4–6], and hemolysis of rabbit erythrocytes are
dependent on the activation of glycerophospholipid metab-
olism [7,8]. We have also demonstrated that the alpha-toxin-
induced hemolysis of sheep erythrocytes is dependent on the
activation of the sphingomyelin metabolic system through
GTP-binding proteins, especially the formation of sphingo-
sine 1-phosphate [9]. We have reported that these biological
activities of alpha-toxin are unable to be separated from the
enzymatic activities [10].0925-4439/$ - see front matter D 2005 Elsevier B.V. All rights reserved.
doi:10.1016/j.bbadis.2005.10.002
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E-mail address: sakurai@ph.bunri-u.ac.jp (J. Sakurai).The three-dimensional structure of alpha-toxin shows two
domains, the N-domain (1–250 residues) and the C-domain
(251–370 residues) [11]. The N-domain contains the active site
and is similar to phospholipase C (PLC) of Bacillus cereus
(BCPLC) [12]. The C-domain is similar to the C2 domain of
intracellular eukaryotic proteins involved in vesicular transport
and signal transduction [11,13]. We reported that alpha-toxin
has two tightly bound zinc metals and an exchangeable
divalent cation: residues His-68, -126 and -136 bind an
exchangeable divalent cation required for binding to mem-
branes, His-148 and Glu-152 bind one zinc ion essential for the
active site of the toxin, and His-11 and Asp-130 tightly bind the
other zinc ion required for maintenance of the structure [14,15].
On the basis of the site-directed mutagenesis of alpha-toxin
and the structure-function relationship of BCPLC, it is
confirmed that a highly conserved motif, zinc coordinating
residues including His, Glu, Asp, and Trp located in a similar
position in the bacterial PLC family and important for the
catalytic activity [16], is essential for binding to metal ions and
enzymatic activities. The conserved motif in alpha-toxin is
present in or near the active site cleft of the N-domain [11].1762 (2006) 110 – 114
http://www
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choline suggests that Tyr-57 and -65, which are exposed
outside of the active site cleft, play a role in the interaction with
substrate (Fig. 1). To investigate the role of the exposed Tyr-57
and -65 close to the active site cleft, we mutated these residues
with various amino acids by site-directed mutagenesis and
analyzed the effect on hemolytic activity, the leakage of
carboxyfluorescein from liposomes, shingomyelinase activity,
and binding to membranes. We here demonstrate that the
membrane-damaging activities of alpha-toxin (hemolysis of
sheep erythrocytes and release of carboxyfluorescein from
liposomes) can be separated from the shingomyelinase activity
of the toxin.
2. Materials and methods
2.1. Materials
Restriction endonucleases and DNA-modifying enzymes were obtained
from Toyobo (Osaka, Japan). Cholesterol, bovine brain sphingomyelin, egg-
yolk phosphatidylcholine, sodium deoxycholate, and carboxyfluorescein
were obtained from Sigma (St. Louis, MO). Horseradish peroxidase-labeled
donkey anti-rabbit immunoglobulin G and an ECL Western blotting kit were
purchased from Amersham Pharmacia Biotech (Tokyo, Japan). 6-Acryloyl-2-
(dimethylamino)-naphthalene (acrylodan) was purchased from Molecular
Probes Co. (Eugene, Ore., USA). All other chemicals were of analytical
grade.
2.2. Bacterial strains
Escherichia coli JM109 and C600 were used as the host for the plasmid.
Bacillus subtilis ISW1214 was used for production of the toxin, as described
previously [14].
2.3. Site-directed mutagenesis
Site-directed mutagenesis was carried out by the unique restriction enzyme
site elimination technique with a Transformer mutagenesis kit (Clontech
Laboratories, Inc., Palo Alto, CA) and synthetic oligonucleotide primers havingFig. 1. Schematic representation of the alpha-toxin’s structure. The structure of
the alpha-toxin obtained from the Protein Data Bank (code 1QM6) was created
by MOE (Chemical Computing Group Inc., Montreal, QC, Canada). Tyr-57
and -65 are shown in a bold-stick and dioleoylphosphatidylcholine is shown in
a stick representation. Dioleoylphosphatidylcholine has been modeled in the
active site.mutations as described previously [14,15]. The plasmid pUAT1 encoding the
entire alpha-toxin gene was used as a template for mutagenesis. Tyr-57 and -5
in the toxin were replaced with Ala, Leu, or Phe. Cysteine substitutions (Y57C
and Y65C) were generated using the cysteine-less variant, C169L, gene as the
template for site-directed mutagenesis. All mutants were obtained by this
method and were identified by sequencing with use of an ABI PRISM 377
sequencer (Applied Biosystems, Foster City, CA).
2.4. Expression and purification of wild-type and variant toxins
The 1.3-kb fragment of wild-type and variant toxins was subcloned from
pUC19 into the pHY300PLK (E. coli –B. subtilis shuttle vector) SmaI site and
transformed into B. subtilis ISW1214 to purify these proteins. Expression and
purification of the wild-type and variant toxins were performed as described
previously [14]. The elution profile of each of the variant toxins was identical to
that of the wild-type toxin on chromatography with a Mono-Q column
(Amersham Pharmacia Biotech).
2.5. Sphingomyelinase activity
Sphingomyelinase activity was measured at 37 -C for 60 min in a
reaction mixture (0.5 ml) containing sphingomyelin dissolved in 0.5%
sodium deoxycholate in 20 mM Tris–HCl buffer (pH 7.5) and 1 mM
CaCl2 as described previously [14]. The reaction was terminated by
adding 1.5 ml of chloroform/methanol/HCl (66/33/1, v/v). The phosphor-
ylcholine formed by the sphingomyelinase activity in the water phase was
converted to acid-soluble phosphate by alkaline phosphatase. The level of
acid-soluble phosphate was measured according to a previously described
method [14].
2.6. Labeling of the sulfhydryl group
Y57C/C169L and Y65C/C169L were thiol-specifically labeled with a 5-
fold molar excess of acrylodan at room temperature for 2 h [17]. DTT, to a final
concentration of 5 mM, was then added to the solution to stop the labeling
reaction. Unreacted acrylodan was removed using Sephadex G-50 (1.520
cm) equilibrated with 20 mM Tris–HCl buffer (pH 7.5) containing 0.9% NaCl
(TBS) and this was verified by the absence of fluorescence at the dye-front of
the UV-transilluminated SDS-PAGE gel.
2.7. Preparation of liposomes and spectrofluorometry of the
toxin-bound liposomes
Sphingomyelin and cholesterol (molar ratio 1:1) were dried from
chloroform/methanol (2:1 v/v) with N2, resuspended in TBS, and sonicated
in a water bath for 5 min to ensure that the lipid was fully hydrated. The
liposome suspension was passed (0.5 ml at a time) 21 times through the
liposome extruder, Liposofast (Avestin Inc., Ottawa, Canada), and polycar-
bonate membranes with a 100-nm pore size [18,19]. Labeled Y57C/C169L and
Y65C/C169L were incubated with liposomes (2.5 Ag of protein per 50 Ag of
total lipid) for 30 min at 37 -C. To remove unbound variant toxins, liposomes
were collected by centrifugation at 15,000 rpm for 20 min and washed twice in
TBS. They were suspended in TBS and analyzed spectrofluorometrically.
Emission spectra were recorded in a Hitachi F-3000 spectrofluorometer
(excitation wavelength of 365 nm for acrylodan; excitation and emission
bandpass of 2 nm) [17,19]. All buffers and liposome preparations were checked
for the absence of significant fluorescence.
2.8. Other assays
Hemolytic activity, phospholipase activity and CD spectra were determined
as described previously [14,20]. Sphingomyelin–cholesterol (1:1) liposomes
containing carboxyfluorescein were prepared, and the release of carboxyfluor-
escein was monitored using a previously described procedure [21]. The binding
to liposomes and sheep erythrocyte membranes of the wild-type and variant
toxins was determined as described previously [14]. The intensity of bands was
quantified with a densitometer (Atto Co., Tokyo, Japan).
Fig. 3. Binding of the wild-type alpha-toxin and variant toxins to sphingo-
myelin–cholesterol liposomes or erythrocyte membranes. Sphingomyelin–
cholesterol (1:1) liposomes or sheep erythrocyte membranes were incubated
with the wild-type or a variant toxin (1 Ag) in the presence of 1 mM Ca2+ at
37 -C for 30 min. The binding of the toxin to the membranes was analyzed by
SDS-PAGE, with Western blotting using anti-alpha-toxin antibody. Lanes: 1,
wild-type toxin; 2, Y57F; 3, Y57L; 4, Y57A; 5, Y65F; 6, Y65L; 7, Y65A.
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3.1. CD spectra
To test whether the replacement of Tyr-57 and -65 in alpha-
toxin causes conformational changes, the wild-type toxin,
Y57A and Y65A were scanned from 190 to 260 nm. Fig. 2
shows that the wild-type and the variant toxins showed a
negative ellipticity at approximately 220 nm, indicating that the
CD spectrum of the variant toxins was not different from that
of the wild-type toxin. CD spectra of Y57F, Y57L, Y65F, and
Y65L also were the same as that of the wild-type (data not
shown). These results showed that these variant toxins have the
same conformation as the wild-type toxin.
3.2. Effect of replacing Tyr-57 and -65 on biological activities
of alpha-toxin
To investigate the membrane-damaging activity, the variant
toxins were incubated with sheep erythrocytes or the liposomes
containing carboxyfluorescein at 37 -C for 30 min. The
mutants of Y57F and Y65F had approximately 70 and 64%
of the hemolytic activity and approximately 62 and 55% of the
membrane-damaging activity, respectively (Table 1), showing
that the substitutions were not wholly effective and the
importance of the hydroxy group at 57 and 62 for those toxic
effects. The hemolysis induced by Y57L and Y57A decreased
approximately 11 and 0.4%, and the leakage of carboxyfluo-
rescein from liposomes decreased approximately 12 and 0.8%,
compared with that caused by the wild-type toxin, respectively.
The activities of Y65L and Y65A also were reduced, to
approximately 9 and 0.6% (hemolytic activity) and 7 and 0.6%
(release of carboxyfluorescein from liposomes), respectively.
The results indicate that these tyrosine residues are important
for the membrane-damaging activity of the toxin.Fig. 2. Circular dichroism spectra of the wild-type alpha-toxin and variant
toxins. The measurement was carried out in protein solutions (100 Ag/ml) with
20 mM phosphate buffer (pH 7.0) using a spectrofluorometer.The sphingomyelinase and phospholipase C activities of
these variant toxins were analyzed with sodium deoxycholate-
solubilized sphingomyelin or phosphatidylcholine. Table 1
shows that replacement of Tyr-57 and -65 resulted in little
change in sphingomyelinase and phospholipase C activities
under the experimental conditions. It therefore appears that
these tyrosine residues are not essential for the enzymatic
activity of the toxin. We reported that H148G has no
phospholipase C activity [14]. As shown in Table 1, H148G
showed no enzymatic activity and did not induce the release of
carboxyfluorescein from sphingomyelin-cholesterol liposomes.
The observation indicates that the enzymatic activity of the
toxin is separated from the biological activities.
3.3. Binding of the variant toxins to liposomes
We tested whether the change of tyrosine residues had any
effect on the binding of the toxin to liposomes and erythrocyte
membranes. The wild-type and variant toxins were incubated
with sphingomyelin–cholesterol liposomes or sheep erythro-
cyte membranes in the presence of 1 mM Ca2+ at 37 -C for 30
min. As shown in Fig. 3, the binding of Y57F and Y65F to
liposomes or erythrocyte membranes did not change, the
binding of Y57L and Y65L decreased slightly, and the binding
of Y57A and Y65A decreased significantly, compared with
that of the wild-type. In addition, a quantitative densitometric
analysis of Western blots for four experiments indicated that
the relative amounts of bound Y57L, Y65L, Y57A and Y65A
were reduced by approximately 75, 70, 50 and 40%, compared
with the amount of wild-type, respectively (data not shown).
Therefore, it appears that Tyr-57 and -65 partially play a role in
the specific binding of the toxin to membranes.
3.4. Binding of acrylodan-labeled variants to liposomes
To investigate the insertion of residues Tyr-57 and -65 of
alpha-toxin into the bilayer of liposomes, we performed a study
using acrylodan attached to single-cysteine substitution variants
(Y57C/C169L and Y65C/C169L). It has been reported that
acrylodan fluorescence intensity causes a blue-shift when the
dye moves from an aqueous to a hydrophobic environment [17].
The binding of staphylococcal alpha-toxin and streptolysin O to
Fig. 4. Interaction of acrylodan-labeled variants with sphingomyelin-cholesterol
liposomes. Acrylodan-labeled Y57C/C169L or Y65C/C169L (100 Ag/ml) was
incubated with sphingomyelin-cholesterol liposomes at 37 -C for 30 min.
Emission spectra of labeled variant toxins were recorded in solution and in the
presence of liposomes.
Table 1
Biological activities of wild-type and variant toxins
Variants Hemolytic
activity (%)
CF-release from
liposome (%)
Sphingomyelinase
activity (%)
Phospholipase
activity (%)
Wild-type 100 100 100 100
Y57F 70.1T8.5 62.4T7.4 105.2T8.9 98.5T5.6
Y57L 11.3T5.3 12.4T3.1 103.1T10.3 102.7T6.1
Y57A 0.4T0.06 0.8T0.05 111.3T9.2 96.8T9.3
Y65F 64.1T9.2 55.4T4.4 95.6T11.3 98.1T4.8
Y65L 8.6T2.7 6.8T1.5 99.2T8.1 101.5T7.5
Y65A 0.6T0.03 0.6T0.03 89.4T7.7 95.8T8.4
Y57C/C169L 31.2T2.6 35.2T5.3 104.1T11.5 95.1T9.3
Y65C/C169L 28.9T3.5 30.2T7.4 98.1T6.1 96.1T8.7
H148G >0.01 >0.01 >0.01 >0.01
Activity (%) was expressed as the percentage of each activity in wild-type toxin. Each value is the mean of five determinations.
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environmental changes, indicative of movement to a hydropho-
bic environment and insertion into a membrane, in a region
containing cysteine residues labeled with the polarity-sensitive
fluorescent probe acrylodan, indicating direct interaction of the
labeled variants with lipids in the bilayer of the membrane
[17,22]. As a control, only the cysteine residue at position 169 in
the wild-type toxin was labeled with acrylodan. The acrylodan-
labeled wild-type toxin possessed the same hemolytic activity as
the unlabeled wild-type toxin and its emission spectrum in
solution did not differ from that in the presence of sphingomye-
lin–cholesterol liposomes, suggesting that position 169 in the
toxin does not enter the hydrophobic environment (data not
shown). Y57C/C169L and Y65C/C169L, which retained about
30% of the lytic activity for liposomes of the wild-type toxin
(Table 1), were labeled with acrylodan. These variant toxins
displayed about 90% of the membrane-damaging activity for
liposomes exhibited by the unlabeled variants, indicating
significant preservation of their ability to bind to membranes.
Fig. 4 shows the emission spectra of acrylodan-labeled variants
in solution and in the presence of the liposomes. Emission
spectra of Y57C/C169L and Y65C/C169L exhibited a marked
blue shift from 526 and 517 nm in the solution to 455 and 439 nm
in the presence of the liposomes, respectively, suggesting that
the environment of the labeled residues became more hydro-
phobic upon the binding to the membrane.
4. Discussion
The findings presented here show that the Tyr-57 and -65
residues in alpha-toxin play a role in the binding to membranes,
but not in the catalytic activity. The substitution of Tyr-57 and -
65 with alanine or leucine had little effect on the sphingomye-
linase activity, but a radical effect on membrane-damaging
activity (hemolysis of sheep erythrocytes and leakage of
carboxyfluorescein from liposomes). Replacement of Tyr-57
and -65 with phenylalanine did not result in a severe decrease
in the membrane-damaging activity or enzymatic activities. It
therefore is unlikely that the phenolic moieties of the side-
chains in amino acid residues at positions 57 and 65 are critical
for the membrane-damaging activity. Several papers have
reported that the C-domain plays an important role in bindingto membranes [3,11,13,19]. However, the replacement of Tyr-
57 and -65 with alanine resulted in a significant decrease in
binding to liposomes and the penetration of these residues into
the bilayer of liposomes. Given that these residues are located
near the entrance of the active site cleft, it seems that Tyr-57
and -65 in alpha-toxin are required for internalization of the
active site cleft in the N-domain into the hydrophobic
environment in membranes to access phospholipids. It there-
fore appears that the side chain of these residues is the key
element in the membrane-damaging action of the toxin.
BCPLC and the N-terminal domain of alpha-toxin have only
28–29% sequence homology [1,2]. The structure of BCPLC
complexed with a phosphatidylcholine-derived phosphonate
inhibitor showed that Tyr-56 and Phe-66 in BCPLC,
corresponding to Tyr-57 and -65 in alpha-toxin, were each
within 5 A˚ of the trimethylammonium cation of the substrate’s
head group [23]. The hydroxyl group of Tyr-57 is approxi-
mately 3.8 A˚ from the methyl groups on the choline moiety,
whereas the centroid of the aromatic ring of Phe-66 lies
approximately 4.2 A˚ from these methyl groups. From the
structure of the complex and the site-directed mutagenesis of
Tyr-57 and Phe-66 in BCPLC, it is suggested that these
residues play roles in binding to the head group of the substrate
M. Nagahama et al. / Biochimica et Biophysica Acta 1762 (2006) 110–114114and modulating the selectivity of BCPLC [24]. We can’t
explain the discrepancy between our result and the result for
BCPLC. However, alpha-toxin possesses phospholipase C,
sphingomyelinase and hemolytic activities, whereas BCPLC
possesses phospholipase C, but not sphingomyelinase or
hemolytic activity. Furthermore, alpha-toxin has an additional
C-terminal domain (120 residues) responsible for binding to
membranes [3,11]. The role of Tyr-57 and -65 residues in the
toxin may be different from that in BCPLC.
In conclusion, Tyr-57 and -65 of the toxin are inserted into
membranes, and the N-domain specifically binds to membranes
and hydrolyses phospholipids. Our results provide new insight
into the membrane-damaging action of the toxin.
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